Stringent Criteria for Low Disease Activity and Remission after 12 Months of Treatment, and after Treatment Withdrawal, with Abatacept Monotherapy, Abatacept with Methotrexate or Methotrexate Alone in Early Rheumatoid Arthritis

Author(s):
Burmester, G.; Furst, D.E.; Combe, B.G.; Huizinga, T.W.J. (0000-0001-7033-7520); Bykerk, V.P.; Wong, D.; Karyekar, C.S.; Emery, P.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Arthritis and Rheumatology (2014), Vol. 66, p. S1076-S1076
hdl
1887/103610